| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $8,760,686 ) (Continued on the next page) |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI100874 | The natural killer cell response against mouse cytomegalovirus infection | 000 | 14 | NIH | 12/8/2025 | $630,290 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA295658 | Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | 000 | 2 | NIH | 12/11/2025 | $606,609 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA276946 | Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer | 000 | 4 | NIH | 12/9/2025 | $462,767 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM144046 | Regulation of protein multi-functionality by 3 UTRs | 000 | 5 | NIH | 12/15/2025 | $637,200 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA261183 | Immune control and genomic instability at micronuclei | 000 | 5 | NIH | 12/23/2025 | $424,822 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA271186 | Probabilistic Multiscale Modeling of the Tumor Microenvironment | 000 | 4 | NIH | 12/17/2025 | $622,736 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MH135403 | Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | 000 | 3 | NIH | 12/2/2025 | $706,519 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 000 | 7 | NIH | 12/11/2025 | $411,861 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA286111 | Backup DNA repair in homologous recombination deficient cancers | 000 | 2 | NIH | 12/5/2025 | $438,654 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA297077 | Metabolic control of malignant fates in lung cancer | 000 | 2 | NIH | 12/5/2025 | $657,361 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA266068 | Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism | 000 | 4 | NIH | 12/17/2025 | $518,111 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA269733 | TOX-driven CD8 T cell differentiation and dysfunction in tumors | 000 | 4 | NIH | 12/30/2025 | $542,566 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG087529 | Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | 000 | 2 | NIH | 12/18/2025 | $783,983 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI034206 | Self-Peptides Bound to MHC Class II in T Cell Selection | 000 | 32 | NIH | 11/26/2025 | $698,720 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R25CA214255 | Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | 000 | 9 | NIH | 12/11/2025 | $102,666 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 000 | 4 | NIH | 12/3/2025 | $718,002 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01CA271287 | Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | 000 | 4 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | T32CA254875 | Molecular Imaging in Cancer Biology Training Program | 000 | 5 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U54CA137788 | 2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach | 000 | 17 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA248289 | Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient | 000 | 6 | NIH | 11/25/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA286330 | Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA277464 | Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life | 000 | 2 | NIH | 12/29/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01DK128615 | Genetic susceptibility to Barrett's esophagus: From GWAS to biology | 000 | 4 | NIH | 11/10/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA294307 | Pilot Feasibility of DESCANSO: Cognitive Behavioral Therapy for Latino Cancer Patients to Treat the Symptom Cluster Depression, Insomnia and Fatigue | 000 | 1 | NIH | 11/19/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244233 | Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | 000 | 5 | NIH | 11/4/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA255655 | Genomic biomarkers of splenic lymphoma | 000 | 6 | NIH | 10/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 000 | 10 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AR068128 | Mechanisms and Function of Myonuclear Positioning | 000 | 10 | NIH | 11/11/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG067598 | Chaperome networks in Alzheimer's disease | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P50CA271357 | MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe | 000 | 4 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P30CA008748 | Cancer Center Support Grant | 000 | 59 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | P30CA008748 | Cancer Center Support Grant | 000 | 59 | NIH | 12/24/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99CA276804 | Targeting Pancreatic Cancer Senescence with ImmunoPET | 000 | 2 | NIH | 12/30/2025 | $0 |
| | 2026 | 2025 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99AI175599 | Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learning | 000 | 2 | NIH | 11/17/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K12CA184746 | MSK Paul Calabresi Career Development Award for Clinical Oncology | 000 | 10 | NIH | 12/23/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | DP5OD033360 | Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis | 000 | 3 | NIH | 12/15/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | UG1CA233332 | ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | 000 | 6 | NIH | 12/18/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | T32CA082088 | T32 Urologic Oncology Research Training Program | 000 | 25 | NIH | 12/30/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R13CA294694 | 7th Annual Workshop on Confocal Microscopy for Cutaneous Diagnostics | 000 | 1 | NIH | 12/8/2025 | -$4,852 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA274717 | Mobile phone-based deep learning algorithm for oral lesion screening in low-resource settings | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA277833 | Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL) | 000 | 2 | NIH | 12/15/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01NS092096 | Signaling Pathways that Regulate Scaling and Regeneration of the Cerebellum | 000 | 10 | NIH | 12/2/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA265026 | Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma | 000 | 3 | NIH | 12/29/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA272733 | Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial | 000 | 3 | NIH | 12/30/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA272678 | Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer: | 000 | 3 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244185 | A Randomized Controlled Trial of Emotion Regulation Therapy for Cancer Caregivers: A Mechanism-Targeted Approach to Addressing Caregiver Distress | 000 | 5 | NIH | 11/20/2025 | -$24,895 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244866 | Exercise as Interception Therapy in Primary High Risk Cancer | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA244532 | Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers | 000 | 5 | NIH | 11/25/2025 | $0 |
| | 2026 | 2024 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA255350 | Circulating biomarkers of ALK+ anaplastic large cell lymphoma | 000 | 5 | NIH | 12/9/2025 | $0 |
|
